Protean BioDiagnostic’s CEO to Speak at 8th International Congress on Cancer Metastasis in San Fransisco
Oct
25
to Oct 27

Protean BioDiagnostic’s CEO to Speak at 8th International Congress on Cancer Metastasis in San Fransisco

Dr. Anthony Magliocco MD, President and CEO of Protean BiDiagnostics will be speaking at the 8th International Congress on Cancer Metastasis in San Fransisco on Oct 25-27.

The talk will explore novel uses of machine learning and analytic microscopy in the diagnosis and prognosis of cancer.

View event website & read about the other speakers

View Event →

Dr. Magliocco to Give Talk on Precision Medicine in Kansas City
Oct
4
7:30 PM19:30

Dr. Magliocco to Give Talk on Precision Medicine in Kansas City

Join Anthony M. Magliocco, President and CEO of Protean BioDiagnostics, for a Dinner Symposium on Precision Medicine. The symposium will center on current and emerging biomarkers: science, technologies, and practicalities, and Dr. Magliocco will review the intricacies of the pre-analytical phase and explore variables that may impact the reliability of laboratory testing, including biomarker results.

To pre-register, please RSVP at 1-866-326-7600 from 8:30 AM – 5:00 PM EST, Monday-Friday using meeting ID 191004-NON-50355. Walk-ins are also welcome!

View PDF for more event details

View Event →
Protean BioDiagnostic’s CEO to Speak at European Annual Meeting on Multiplex Histopathology
Sep
12
9:00 AM09:00

Protean BioDiagnostic’s CEO to Speak at European Annual Meeting on Multiplex Histopathology

Protean BioDiagnostic’s CEO Dr. Anthony Magliocco MD  will be speaking at the European Annual Meeting on Multiplex Histopathology, on September 12th at Montpellier.

The meeting is centered around the possibilities of Multiplex Histopathology in phenotyping and physiopathological mechanisms, and in aiding our understanding of major diseases.

View event website for information + registration

View Event →
Protean BioDiagnostic's CEO to Present Webinar on Current and Emerging Biomarkers in Immuno-Oncology
Sep
5
12:00 PM12:00

Protean BioDiagnostic's CEO to Present Webinar on Current and Emerging Biomarkers in Immuno-Oncology

Dr. Anthony Magliocco, the Protean BioDiagnostics CEO will be presenting an update webinar on current and emerging biomarkers in immuno-oncology, on September 5th.

Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies. This webinar will empower you to understand the biology behind current and emerging immuno-oncology biomarkers.

Some of the learning objectives of the webinar are : review of the immune system and cancer, current and Emerging predictive I-O biomarkers, and biomarker testing practicalities.

Register for the webinar on the event website

View Event →
Jul
31
to Aug 2

Dr. Magliocco Invited to Speak at Inspirata Executive Exchange

Dr. Anthony Magliocco MD, President and CEO Protean BiDiagnostics will be speaking at the Inspirata Executive Exchange. The meeting will center on practical advantages in cancer care and research, and will take place between July 31st and August 2nd 2019.

View event website for information + registration

View Event →
Jun
11
to Jun 12

Protean BioDiagnostics' CEO to Join Panelists at Precision Medicine Leaders Summit

  • Rubenstein Auditorium, UPenn School of Medicine (map)
  • Google Calendar ICS

Dr Magliocco CEO and President of Protean BioDiagnostics will be a panelist discussing the impact of digital pathology on precision medicine diagnostics at the Precision Medicine Leaders Summit East in Philadelphia June 11 and 12

Protean BioDiagnostics has recently partnered with  the AI technology leader Nucleai to comercialize advanced AI based diagnostics into the US pathology market with an initial target focus on improving quality of prostate cancer pathology diagnosis in urology practices

View event website for information + registration

View Event →